You are here

breast cancer

AstraZeneca and Daiichi Sankyo’s Enhertu shows promise in breast cancer trial

Clinical Trials Arena

Mon, 04/29/24 - 11:12 am

HER2-low breast cancer

Breast Cancer Detection Drug-Device System Nabs FDA Approval

Medical Devices and Diagnostics Industry

Mon, 04/22/24 - 05:51 pm

optical imaging

QT imaging’s breast imaging system proves as effective as mammography

Clinical Trials Arena

Wed, 04/17/24 - 11:15 am

Breast Acoustic

Novartis pauses enrollment in some Kisqali trials to fix manufacturing

BioPharma Dive

Wed, 04/10/24 - 05:28 pm

drug manufacturing

clinical trials

AZ, Daiichi Sankyo file Dato-DXd for second indication

Pharmaphorum

Tue, 04/2/24 - 11:31 am

FDA panel backs Lumicell’s agent for breast cancer imaging tool

Medtech Dive

Mon, 03/11/24 - 11:56 am

Pfizer funnels $15M into 3-year ACS initiative designed to tackle cancer care disparities

Fierce Biotech

Mon, 02/5/24 - 10:23 am

American Cancer Society

clinical trials

pharma marketing

prostate cancer

BioNTech challenges AstraZeneca with breast cancer precision drug trial

Reuters

Mon, 01/22/24 - 11:15 am

Duality Biologics

clinical trials

HER2+ breast cancer

Seagen seeks new approval for Tukysa in HER2+ breast cancer

Clinical Trials Arena

Mon, 12/18/23 - 11:32 am

HER2+ breast cancer

Novartis gears up for label expansion for Kisqali with Phase III results

Clinical Trials Arena

Mon, 12/11/23 - 11:18 am

clinical trials

early breast cancer

Roche reports positive Phase III data for breast cancer therapy

Clinical Trials Arena

Tue, 12/5/23 - 09:56 am

clinical trials

metastatic breast cancer

AstraZeneca’s AKT Inhibitor Wins FDA Approval for Combo Breast Cancer Treatment

BioSpace

Sun, 11/19/23 - 09:36 pm

FDA Approves Truqap Plus Faslodex for Advanced HR-Positive Breast Cancer

Pharm Exec

Fri, 11/17/23 - 10:09 am

Olema scores in Phase II breast cancer trial with Phase III dosing in weeks

Clinical Trials Arena

Mon, 10/23/23 - 09:10 am

clinical tirals

Seagen wins future royalties in Enhertu patent dispute

Pharmaphorum

Wed, 10/18/23 - 10:07 am

BioNTech takes another leaf out of Daiichi playbook, paying $70M for HER3-directed ADC

Fierce Biotech

Thu, 10/12/23 - 10:07 am

antibody-drug conjugate

Daiichi Sankyo reports positive results from trial of breast cancer therapy

Clinical Trials Arena

Mon, 09/25/23 - 11:47 am

clinical trials

AstraZeneca, Daiichi Tout Phase III Breast Cancer Data in Challenge to Gilead

BioSpace

Fri, 09/22/23 - 11:51 am

antibody-drug conjugate

clinical trials

Seagen’s breast cancer therapy meets main goal in late-stage study

Medical Marketing and Media

Wed, 08/16/23 - 11:34 pm

clinical trials

Merck's Keytruda meets main goal in late-stage breast cancer study

Reuters

Sat, 07/29/23 - 10:40 pm

clinical trials

Pages